Manulife (Manufacturers Life Insurance)
LUMO

Manulife (Manufacturers Life Insurance)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-108
Closed -$5K – 3936
2018
Q2 		$5K Sell
108
-2,621
-96% -$120K ﹤0.01% 4092
2018
Q1 		$178K Buy
2,729
+87
+3% +$6.16K ﹤0.01% 3106
2017
Q4 		$193K Buy
2,642
+605
+30% +$50K ﹤0.01% 3029
2017
Q3 		$186K Sell
2,037
-82
-4% -$6.29K ﹤0.01% 3040
2017
Q2 		$140K Buy
2,119
+62
+3% +$7.68K ﹤0.01% 3254
2017
Q1 		$446K Buy
2,057
+230
+13% +$32.9K ﹤0.01% 2281
2016
Q4 		$169K Buy
1,827
+63
+4% +$7.1K ﹤0.01% 2921
2016
Q3 		$238K Hold
1,764
– – ﹤0.01% 2643
2016
Q2 		$179K Sell
1,764
-4,827
-73% -$598K ﹤0.01% 2797
2016
Q1 		$1.02M Buy
6,591
+29
+0.4% +$5.88K ﹤0.01% 1605
2015
Q4 		$2.15K Buy
6,562
+15
+0.2% +$4.88K ﹤0.01% 1383
2015
Q3 		$2.11K Sell
6,547
-833
-11% -$366K ﹤0.01% 1364
2015
Q2 		$2.94K Sell
7,380
-3
-0% -$1.27K ﹤0.01% 1303
2015
Q1 		$3.63K Sell
7,383
-1,881
-20% -$729K ﹤0.01% 1194
2014
Q4 		$3.31K Sell
9,264
-2,447
-21% -$728K ﹤0.01% 1174
2014
Q3 		$2.26K Buy
11,711
+10,245
+699% +$2.25M ﹤0.01% 1291
2014
Q2 		$350K Sell
1,466
-4
-0.3% -$813 ﹤0.01% 2305
2014
Q1 		$376 Sell
1,470
-72
-5% -$22K ﹤0.01% 2274
2013
Q4 		$306 Sell
1,542
-55
-3% -$9.78K ﹤0.01% 2400
2013
Q3 		$269 Sell
1,597
-66
-4% -$10.6K ﹤0.01% 2433
2013
Q2 		$295K Buy
+1,663
New +$235K ﹤0.01% 2263

Other funds holding LUMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LUMO Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2018, closing a stake of 108 shares — an estimated $5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in LUMO in Q2 2013 and held it in 21 quarters. The position peaked at $1.02M in Q1 2016. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 108 Lumos Pharma, Inc. Common Stock shares in Q3 2018, an estimated $5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Lumos Pharma, Inc. Common Stock position peaked at $1.02M in Q1 2016.
  • 92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.